Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

NCT02308137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Secondary Progressive

Interventions

DRUG: Domperidone

Sponsor

University of Calgary

Collaborators

[object Object]